Back
Speaker illustration

Associate Professor Michael Blazing

Duke Clinical Research Institute, Durham (United States of America)

Presentations

Comparative efficacy of ezetimibe plus simvastatin combined therapy vs. simvastatin monotherapy for individuals with reduced estimated glomerular filtration rate

Event: ESC Congress 2016

Topic: Drug therapy

Session: Lipid-lowering agents - New perspectives

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources